COMP <GO>
PODD vs LLY // REVENUE GROWTH (YOY)
Insulet Corporation (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: PODD 3
— LLY 12
▲ REVENUE GROWTH (YOY) LEADER: LLY
LAST: $149.68 (-1.85%) • MKT CAP: $10.58B
revenue-growth
30.70%
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
revenue-growth
45.51%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PODD VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PODD | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.60% | 83.64% | -12.04 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.40% | 32.36% | -11.96 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.1x | 36.4x | -19.32 | PODD | /valuation <GO> |
| Free Cash Flow Yield | 3.57% | 2.30% | +1.27 | PODD | /fcf-yield <GO> |
| Operating Margin | 17.50% | 40.21% | -22.71 | LLY | /operating-margins <GO> |
| Net Profit Margin | 9.10% | 31.90% | -22.80 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 30.70% | 45.51% | -14.81 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.72 | 9.29 | -3.57 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.77% | +0.13 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.4 | 77.9 | -15.53 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 0.51 | +0.48 | PODD | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 26.3x | +9.75 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.58B | $1.33T | -$1.32T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PODD REV | LLY REV | PODD GROSS % | LLY GROSS % | PODD FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.71B | $65.18B | 71.6% | 83.0% | $377.7M | $16.81B |
| FY 2024 | $2.07B | $45.04B | 69.8% | 81.3% | $305.3M | $8.82B |
| FY 2023 | $1.70B | $34.12B | 44.0% | 79.3% | $69.3M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PODD // BETA 0.99
LLY // BETA 0.51